Federal award (PURCHASE ORDER, fiscal year 2024)
Recipient: MEDPHARM INC.
Awarding agency: Department of Defense / Defense Health Agency
Funding agency: Department of Defense / Defense Health Agency
Period of performance: 2022-09-07 to 2026-09-30
Current total value of award: $683362.8
Description: REAGENTS AND ANALYZER